Literature DB >> 16462733

The NuRD component Mbd3 is required for pluripotency of embryonic stem cells.

Keisuke Kaji1, Isabel Martín Caballero, Ruth MacLeod, Jennifer Nichols, Valerie A Wilson, Brian Hendrich.   

Abstract

Cells of early mammalian embryos have the potential to develop into any adult cell type, and are thus said to be pluripotent. Pluripotency is lost during embryogenesis as cells commit to specific developmental pathways. Although restriction of developmental potential is often associated with repression of inappropriate genetic programmes, the role of epigenetic silencing during early lineage commitment remains undefined. Here, we used mouse embryonic stem cells to study the function of epigenetic silencing in pluripotent cells. Embryonic stem cells lacking Mbd3 - a component of the nucleosome remodelling and histone deacetylation (NuRD) complex - were viable but failed to completely silence genes that are expressed before implantation of the embryo. Mbd3-deficient embryonic stem cells could be maintained in the absence of leukaemia inhibitory factor (LIF) and could initiate differentiation in embryoid bodies or chimeric embryos, but failed to commit to developmental lineages. Our findings define a role for epigenetic silencing in the cell-fate commitment of pluripotent cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16462733     DOI: 10.1038/ncb1372

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  196 in total

Review 1.  Epigenetic landscape of pluripotent stem cells.

Authors:  Ji Woong Han; Young-sup Yoon
Journal:  Antioxid Redox Signal       Date:  2012-01-11       Impact factor: 8.401

2.  Differential regulation of HIC1 target genes by CtBP and NuRD, via an acetylation/SUMOylation switch, in quiescent versus proliferating cells.

Authors:  Capucine Van Rechem; Gaylor Boulay; Sébastien Pinte; Nicolas Stankovic-Valentin; Cateline Guérardel; Dominique Leprince
Journal:  Mol Cell Biol       Date:  2010-06-14       Impact factor: 4.272

Review 3.  Induced pluripotency: history, mechanisms, and applications.

Authors:  Matthias Stadtfeld; Konrad Hochedlinger
Journal:  Genes Dev       Date:  2010-10-15       Impact factor: 11.361

4.  Metastasis tumor antigen 2 (MTA2) is involved in proper imprinted expression of H19 and Peg3 during mouse preimplantation development.

Authors:  Pengpeng Ma; Shu Lin; Marisa S Bartolomei; Richard M Schultz
Journal:  Biol Reprod       Date:  2010-08-18       Impact factor: 4.285

5.  BEND3 mediates transcriptional repression and heterochromatin organization.

Authors:  Abid Khan; Supriya G Prasanth
Journal:  Transcription       Date:  2015-10-27

6.  Differential recruitment of methylated CpG binding domains by the orphan receptor GCNF initiates the repression and silencing of Oct4 expression.

Authors:  Peili Gu; Damien Le Menuet; Arthur C-K Chung; Austin J Cooney
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

7.  CHD4/Mi-2beta activity is required for the positioning of the mesoderm/neuroectoderm boundary in Xenopus.

Authors:  Britta Linder; Edith Mentele; Katrin Mansperger; Tobias Straub; Elisabeth Kremmer; Ralph A W Rupp
Journal:  Genes Dev       Date:  2007-04-15       Impact factor: 11.361

Review 8.  Chromatin dynamics: interplay between remodeling enzymes and histone modifications.

Authors:  Sarah G Swygert; Craig L Peterson
Journal:  Biochim Biophys Acta       Date:  2014-02-28

9.  Loss of RBBP4 results in defective inner cell mass, severe apoptosis, hyperacetylated histones and preimplantation lethality in mice†.

Authors:  Xiaosu Miao; Tieqi Sun; Holly Barletta; Jesse Mager; Wei Cui
Journal:  Biol Reprod       Date:  2020-06-23       Impact factor: 4.285

10.  Deterministic direct reprogramming of somatic cells to pluripotency.

Authors:  Yoach Rais; Asaf Zviran; Shay Geula; Ohad Gafni; Elad Chomsky; Sergey Viukov; Abed AlFatah Mansour; Inbal Caspi; Vladislav Krupalnik; Mirie Zerbib; Itay Maza; Nofar Mor; Dror Baran; Leehee Weinberger; Diego A Jaitin; David Lara-Astiaso; Ronnie Blecher-Gonen; Zohar Shipony; Zohar Mukamel; Tzachi Hagai; Shlomit Gilad; Daniela Amann-Zalcenstein; Amos Tanay; Ido Amit; Noa Novershtern; Jacob H Hanna
Journal:  Nature       Date:  2013-09-18       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.